This is in line with previous studies, which have consistently shown that serum NfLs are a reliable proxy for CSF NfL concentrations in different neurological diseases, albeit measurable in smaller concentrations [24,39,40,41]. The gene discussed is NEFL; the disease is nervous system disorder.